is HPV16 E7 Oncoprotein Labile if it is Unliganded?
- 30 September 2025
- journal article
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 15 (3) , 489-494
Abstract
Objective: Human papillomavirus (HPV) infection is a major global health concern due to its association with several types of cancer, particularly cervical cancer. Among the various viral proteins produced by HPV, E6 and E7 oncoproteins have been identified as key players in the oncogenic transformation of infected cells. HPV E7 oncoprotein primarily targets the retinoblastoma protein (pRb) and related family members, retinoblastoma-like protein 2 (p130) and retinoblastoma-like protein 1 (p107) and disrupts their association with E2F transcription factors, releasing the E2F for transcriptional activation of genes required for cell cycle progression. E7 is an unstable protein with a half-life of less than 2 hours. We aimed to investigate whether the stability of the E7 protein would change when it has a binding partner such as pRb, p130 and p107. Methods: We transfected HEK293T cells with either Green Fluorescent Protein tagged E7 (GFP-E7) construct alone or together with one of the pRb (RB1), p130 (RBL2) or p107 (RBL1) constructs and observed the expression of GFP-E7 under a fluorescent microscope. We have also analysed the expression levels of E7, pRb, p130 and p107 by western blotting using specific antibodies. Results: We showed that E7 expression was more prominent in human embryonic kidney 293T (HEK293T) cells where one of the cellular target proteins was co-expressed. Conclusion: HPV E7 oncoprotein is an indispensable component for the pathogenesis of cervical cancer, and understanding the molecular mechanisms of how E7 maintains its stability in the cell may enable the development of targeted treatment approaches.Keywords
This publication has 29 references indexed in Scilit:
- Evidence for direct interaction between the oncogenic proteins E6 and E7 of high-risk human papillomavirus (HPV)Journal of Biological Chemistry, 2023
- The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic TargetsTrends in Microbiology, 2018
- Identification of the nuclear localization and export signals of high risk HPV16 E7 oncoproteinVirology, 2009
- The N-Terminal Module of HPV16 E7 Is an Intrinsically Disordered Domain That Confers Conformational and Recognition Plasticity to the OncoproteinBiochemistry, 2007
- Molecular interactions of ‘high risk’ human papillomaviruses E6 and E7 oncoproteins: implications for tumour progressionJournal of Biosciences, 2003
- High-Risk (HPV16) Human Papillomavirus E7 Oncoprotein Is Highly Stable and Extended, with Conformational Transitions that Could Explain Its Multiple Cellular Binding PartnersBiochemistry, 2002
- The E7 Oncoprotein of Human Papillomavirus Type 16 Interacts with F-Actin in Vitro and in VivoVirology, 2000
- Dimerization of the Human Papillomavirus E7 Oncoproteinin VivoVirology, 1995
- HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.The EMBO Journal, 1989
- The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1ACell, 1988